凯里小苔找房营销策划
20-99人
公司优势
公司累计运营项目超16个，物业类型涵盖高层、洋房、别墅、公寓、商业。
20,861+ 岗位更新等你来订阅
一键订阅最新的岗位，每周送达
🎉恭喜你，订阅成功
继续订阅您可以在邮箱中随时取消订阅
衡水沁洋医疗器械商贸有限公司，成立于2015年，位于河北省衡水市，主营零售业。
埃森压缩机有限公司是一家集整机销售、配件供应、售后服务、信息反馈于一体的专业压缩机销售服务公司，主要代理英格索兰V系列、LX系列、德国德励等品牌的压缩机销售与售后服务。公司始终坚持品质第一、用户至上的原则，以可靠的质量、合理的价位、良好的售前售后服务，为用户提供高品质的空气压缩机和创新的高技能解决方案，为客户创造最大效益，与合作伙伴共同成长。公司技术人员每年接受英格索兰公司培训，技术扎实，产品卓越，24小时售后服务随叫随到。公司提供以下客户服务：1.免费现场指导安装调试；2.免费人工维修；3.免费现场问题检测；4.免费定期设备巡检，及时排除隐患，避免停机。欢迎来电来函咨询与洽谈。
Morris Group is an engineering and design consultancy company with the longest history in Europe. Based in the UK, it has five regional offices there as well. It also has dozens of overseas branches and offices across Europe, the Middle East, Asia, and North America, employing over a thousand professional technical staff. Since its inception in 2003, Morris China has committed itself to providing "all-in-one" service in planning and consultation for various types of clients. Whether dealing with private enterprises or public institutions such as municipal governments, investors, companies, developers, hotel operators, or factory owners, whether politically or economically involved, Morris China, with its highly trained team members possessing diverse specialties, is fully capable of offering the most favorable and comprehensive solutions.
The founder of the company, William Morris, was the main representative of the Arts and Crafts Movement. The Morris & Webb design office established in 1864 with Pre-Raphaelite artists became the predecessor of Morris Group. After more than a hundred years of evolution and development, Morris Group has become a multinational corporation with diversified professional fields, covering pre-project analysis, urban planning, urban design, various architectural services including landscape design, and providing full-process solutions from planning to implementation.
As the branch of Morris Group in the Far East, Morris China entered the Chinese market in 2003 and set up an office in Shanghai in 2007. With strong support from the headquarters, Morris China combines international experience with local realities, achieving remarkable project results in China's urbanization process. The headquarters of Morris China is located in Shanghai, with branches in Hong Kong, Beijing, Wuhan, Suzhou, and Shenzhen. The group consists of four major business sectors: asset investment, engineering design, commercial operations, and sales agency. The company gathers top domestic and international professionals and experts in various fields to provide specialized solutions for urban development in China, including planning, architecture, municipal works, landscaping, and interior design. It also provides services such as fund issuance, research and development, project consulting, operational management, and sales agency for government public institutions and real estate developers.
Since its establishment in 2003, Morris China has been dedicated to providing one-stop "full-chain" consulting services for various types of owners. Regardless of whether dealing with private owners or public institutions such as city governments, investors, companies, developers, hotel operators, or industrial owners, whether politically or economically involved, Morris China has sufficient capability to organize teams with multiple professional backgrounds to offer the most preferred and comprehensive solutions.
Subsidiaries and controlled companies under Morris China include: Moren (Shanghai) Architectural Consulting Co., Ltd., Moreheng Real Estate Consulting (Shanghai) Co., Ltd., Shenzhen Morris Fund Management Co., Ltd., Wuhan Yidao Real Estate Agency Co., Ltd.
青少年篮球，中考体育项目
深圳市默赛尔生物医学科技发展有限公司（简称默赛尔生物）是一家为国内外生物治疗公司、医疗机构、高校及科研院所等提供全领域细胞治疗产品和技术解决方案的国家高新技术企业。
默赛尔生物拥有一支由战略科学家、科技领军人才和高技能人才组成的专家团队，在恶性肿瘤、自身免疫性疾病、乙型肝炎的免疫细胞治疗以及组织损伤和退行性疾病的干细胞治疗等领域开展关键核心技术的研发与应用，其综合实力处于国际先进、国内领先地位。
默赛尔生物还致力于为从事细胞治疗研究的科研人员提供高质量的科研服务，拥有分子克隆、蛋白纯化、细胞培养、病毒制备、免疫评估五大技术平台，可以提供质粒构建、稳定细胞系筛选、病毒包装、流式检测、免疫功能评估和大规模细胞培养等服务。
默赛尔生物拥有先进的“细胞治疗研发中心”，总面积达1300平方米，其中包括600平方米的高洁净度、高标准cGMP实验室，形成了从实验研究、中试、生产到临床应用全过程模式的细胞治疗产业科技创新实体。该中心不仅能满足技术研发、人员培训和大批量细胞培养的需求，还有力推动了科技成果的资本化和产业化进程。此外，默赛尔生物于2017年9月全资注册成立了深圳默赛尔医学检验实验室，新建成约600平方米的临床免疫检验实验室，主要为健康管理机构提供人体免疫功能评估相关检测服务。
默赛尔生物目前拥有6个I类医疗器械产品、2个广东省高新技术产品和2个II类医疗器械产品正处于临床试验阶段。在核心技术方面，默赛尔生物共拥有9项专利技术，其中6项已获授权，包括嵌合抗原受体修饰自然杀伤细胞（CAR-NK）抗肿瘤治疗技术。其研发的双靶点CAR-NK细胞能够更快速精准地识别并杀伤恶性肿瘤细胞，并配备有安全性开关，已完成临床前研究，疗效和安全性指标良好，即将作为细胞治疗药物申请上市批文。此外，公司还建立了临床级慢病毒包装制备体系，以满足基因修饰细胞治疗技术对临床级慢病毒的大量需求。
默赛尔生物是细胞治疗产业的科技创新联盟，已与牛津大学、伯明翰大学、西安交通大学、哈尔滨工业大学等知名高校建立了战略合作关系，具有国际与国内相统筹的专业视野。
默赛尔生物愿与国内细胞治疗产业的同行们共同唱响“中国制造”的最强音！